Clinical Trial Update: A Study to Evaluate Flexible Dose of Paliperidone Extended Release (ER) and Clinical Response in Participants With Schizophrenia [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial update reports the results of a flexible-dose paliperidone extended-release regimen in adults with schizophrenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Paliperidone ER (paliperidone)

Snippet

Sponsor: Johnson & Johnson Taiwan Ltd | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED | Results posted: 2014-01-14